About Cambridge Major Laboratories
Cambridge Major Laboratories is a Healthcare company based in Milwaukee (United States) founded in 1999, and was acquired by Arlington Capital Partners in February 2007. It provides API, intermediates, and finished dosage form development and manufacturing services. It operates on a B2B model. Its focus areas include Pharmaceuticals, Drug Manufacturing and API Development. Its competitors include Asymchem, Continuus Pharma and Pharmaceutics International; 1 of its 3 listed competitors has raised funding.
Company details
Cambridge Major Laboratories operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and api development. Provides API, intermediates, and finished dosage form development and manufacturing services. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Milwaukee, United States
- Stage Acquired
- SectorsHealthcare
- Website c-mlabs.com
- Acquired by Arlington Capital Partners (Feb 2007)
- InvestorsNewStar Financial
& 1 more
- Acquired byArlington Capital Partners
(Feb 2007)
Funding Insights of Cambridge Major Laboratories
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Cambridge Major Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2007 | Debt – Conventional | – | – |
2 investors in total: 2 institutional.
Investors in Cambridge Major Laboratories
Cambridge Major Laboratories has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include NewStar Financial and Arlington Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on investments in regulated industries. | arlingtoncap.com | |||
Financial services are provided by NewStar Financial in Boston. | 2004 | newstarfin.com | Boston, United States |
Investor details for Cambridge Major Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cambridge Major Laboratories
3 dated milestones of Cambridge Major Laboratories across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Cambridge Major Laboratories is founded.
- Funding First funding round.
- Exit Acquired by Arlington Capital Partners.
Competitors of Cambridge Major Laboratories
Cambridge Major Laboratories has 3 listed competitors in our database, 1 of them funded. They include Asymchem, Continuus Pharma and Pharmaceutics International.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asymchem.com | 1995 | Morrisville, United States | 48 | APIs and peptides are developed and manufactured by Asymchem. | ||
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | |
| pharm-int.com | 1994 | Hunt Valley, United States | 248 | Pharmaceutical dosage forms are manufactured by this CDMO. |
Detailed competitors of Cambridge Major Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cambridge Major Laboratories
Websites that share an audience with Cambridge Major Laboratories (c-mlabs.com).
Websites whose visitors overlap most with Cambridge Major Laboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cancergenetics.com | 100% | View details | |||
| halopharma.com | 94% | 3.2K | #13,721,549 | View details |
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Cambridge Major Laboratories (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 61.16 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cambridge Major Laboratories
Cambridge Major Laboratories was founded in 1999 and raised its 1st funding round 8 years after it was founded.
Cambridge Major Laboratories is headquartered in Milwaukee, United States. It is registered at Milwaukee, Wisconsin, United States.
Cambridge Major Laboratories operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and api development. Provides API, intermediates, and finished dosage form development and manufacturing services. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Cambridge Major Laboratories's top competitors include Pharmaceutics International, Asymchem and Continuus Pharma.
Cambridge Major Laboratories has 2 investors. Key investors include NewStar Financial, and Arlington Capital Partners.
Yes. Cambridge Major Laboratories was acquired by Arlington Capital Partners in February 2007.